A pocket guide to manage pediatric emergencies, an app to help diagnose a variety of eye conditions, and 3 other must-have emergency medicine apps for primary care physicians.
Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD
Verekitug is the only biologic in development for COPD that targets the TSLP receptor directly.
The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment
Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.
Real-World Data Highlight Impact of Treatment Discontinuation on Obesity Pharmacotherapy Outcomes
A recent study highlights the importance of medication adherence for significant weight loss and improved glycemic control in obesity treatment with GLP-1 agonists.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status: Transcend Therapeutics Update
TSND-201, a rapid-acting neuroplastogen, demonstrated statistically significant symptom improvement by day 10, which was durable throughout the study until Day 64.
Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment
The FDA approved updated dosing for donanemab in early Alzheimer disease, reducing ARIA-E risk by 41% without compromising efficacy.